Avid Bioservices Inc (CDMO)
11.93
-0.27
(-2.21%)
USD |
NASDAQ |
Nov 14, 16:00
11.92
-0.01
(-0.08%)
After-Hours: 20:00
Avid Bioservices Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| October 31, 2016 | 7.022M |
| July 31, 2016 | 8.569M |
| April 30, 2016 | |
| January 31, 2016 | 15.16M |
| October 31, 2015 | 14.19M |
| July 31, 2015 | 13.92M |
| April 30, 2015 | 11.53M |
| January 31, 2015 | 11.26M |
| October 31, 2014 | 10.00M |
| July 31, 2014 | 10.20M |
| April 30, 2014 | 8.813M |
| January 31, 2014 | 6.649M |
| October 31, 2013 | 6.957M |
| July 31, 2013 | 5.304M |
| April 30, 2013 | 5.835M |
| January 31, 2013 | 5.437M |
| October 31, 2012 | 6.053M |
| July 31, 2012 | 6.981M |
| April 30, 2012 | 8.93M |
| January 31, 2012 | 9.18M |
| October 31, 2011 | 9.818M |
| July 31, 2011 | 7.76M |
| April 30, 2011 | 7.998M |
| January 31, 2011 | 7.053M |
| October 31, 2010 | 7.344M |
| Date | Value |
|---|---|
| July 31, 2010 | 7.067M |
| April 30, 2010 | 7.13M |
| January 31, 2010 | 7.322M |
| October 31, 2009 | 4.132M |
| July 31, 2009 | 6.074M |
| April 30, 2009 | 5.59M |
| January 31, 2009 | 4.465M |
| October 31, 2008 | 4.301M |
| July 31, 2008 | 4.068M |
| April 30, 2008 | 4.614M |
| January 31, 2008 | 4.941M |
| October 31, 2007 | 5.10M |
| July 31, 2007 | 3.624M |
| April 30, 2007 | 4.008M |
| January 31, 2007 | 3.907M |
| October 31, 2006 | 3.92M |
| July 31, 2006 | 4.041M |
| April 30, 2006 | 3.085M |
| January 31, 2006 | 3.294M |
| October 31, 2005 | 3.244M |
| July 31, 2005 | 2.792M |
| April 30, 2005 | 3.042M |
| January 31, 2005 | 2.548M |
| October 31, 2004 | 3.004M |
| July 31, 2004 | 2.57M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| MEI Pharma Inc | 3.944M |
| Altimmune Inc | 21.16M |
| NovaBay Pharmaceuticals Inc | 0.009M |
| Palatin Technologies Inc | 4.672M |
| iBio Inc | 1.14M |